First derivation of human embryonic stem cells without exposure to cell feeders
To-date, all human embryonic stem cell lines have been isolated in contact with either mouse or human cells that may have contaminated the stem cells with viruses or other pathogens. It is therefore likely that the human embryonic stem cell lines authorized for federal research funding under the President's August 9, 2001 policy are therefore unsuitable for use in transplant medicine. "The ability to generate embryonic stem cells without exposure to living cells or serum solves a major problem associated with the use of these cells in future medical therapies," said Robert Lanza, Vice President of Medical & Scientific Development at ACT, and senior author of the study. "There are unique challenges associated with the earliest stages of stem cell derivation. Our study shows that the cell- and serum-free derivation of new embryonic stem cell lines is possible from the beginning."
Although feeder-free systems have been described in the past, they have all been used for the maintenance of previously-established human embryonic stem cell lines that have already been exposed to potential contamination by contact with such animal cells.
The extracellular-matrix-coated plates used in ACT's study proved remarkably stable, and could be easily sterilized using a variety of conventional treatment and sterilization processes. This work also represents an important step toward a completely animal product-free culture system for the derivation and maintenance of new "clean" embryonic stem cell lines.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.